Full Text
PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in Italy

Abstract

Authors

A. Marcellusi M.F. Botteman S. Rao M. Cifaldi C.T. Solem L. Gitto P. Giannantoni F.S. Mennini

Back to Volume 15, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×